WHO Reports Shortage of Covid Treatment Medicine
WHO and Unitaid are concerned by pharmaceuticals company Roche’s statement, warning of a global shortage of tocilizumab (brand name Actemra/RoActemra), an IL6 inhibitor WHO recommended in June for use as…
